Researchers identify risks for death from H7N9 avian flu virus

December 24, 2013 by Marcia Malory report
Influenza A (H7N9) as viewed through an electron microscope. Both filaments and spheres are observed in this photo. Credit: CDC

(Medical Xpress)—Since March 2013, the avian flu virus H7N9 has infected 134 people and caused 44 deaths. Among those infected, many, but not all, patients develop severe symptoms, including pneumonia and acute respiratory distress syndrome (ARDS), that can eventually result in death. Until now, scientists have not understood why the disease affects some more severely than others. Peter Doherty and his colleagues have found that patients with high levels of certain cytokines are more likely to suffer severe lung and airway damage than patients with lower levels of these cytokines. They also discovered that patients who carry a particular variant of the gene that codes for the protein IFITM3 are more likely to suffer severe symptoms and to die than patients with other versions of the gene. The research appears in the Proceedings of the National Academy of Sciences.

Previous research has shown that H7N9 patients with elevated plasma cytokine levels tend to experience poor outcomes. To study the relationship between cytokine levels and disease progression further, Doherty and his team took blood plasma samples from 18 patients infected with H7N9 who were admitted to the Shanghai Public Health Clinical Center. Eventually, 12 of the patients recovered and six died. The researchers found that blood levels of the cytokines Il-6 and Il-8 were 10 times higher than normal in all of the patients who died. Only one of the patients who survived had such high levels of these cytokines. The patients who died also had elevated levels of the cytokines IL-10 and macrophage inflammatory MIP -1β.

The team also examined samples from bronchoalveolar lavages performed on three of the patients, all of whom died. Concentrations of the cytokines IL-1β, IL-6, and IL-8 were one thousand times higher than normal, while concentrations of MIP-1α and MIP-1β were one hundred times higher than normal.

When the team sequenced the subjects' DNA, they found that patients with a variant of the gene that codes for IFN-induced transmembrane protein-3 (IFITM3), known as IFITM3 C/C, suffered more severe symptoms, required medical intervention sooner and were less likely to survive than patients with the variants IFITM3 T/C and IFITM 3 T/T. IFITM3 can prevent flu virus particles from entering the cytoplasm and thus prevent the virus from replicating. Subjects with the C/C variant had higher plasma levels of IL-6, IL-8, and MIP-1β. During the 2009 H1N1 avian flu outbreak, patients with the C/C variant also had elevated plasma cytokine levels and experienced worse outcomes.

The researchers suggest that screening for the IFTM3 genotype and monitoring of plasma levels can help ensure that diagnosed with H7N9 infection receive proper treatment.

Explore further: Genetic clue to fighting new strains of flu

More information: Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection, PNAS, Published online before print December 23, 2013, DOI: 10.1073/pnas.1321748111

A unique avian-origin A/H7N9 influenza virus has so far caused 134 cases with 44 deaths. Probing the host factors contributing to disease severity, we found that lower levels of plasma inflammatory cytokines on hospital admission correlated with faster recovery in 18 patients with A/H7N9 influenza virus, whereas high concentrations of (in particular) IL-6, IL-8, and macrophage inflammatory protein-1β were predictive of a less favorable or fatal outcome. Analysis of bronchoalveolar lavage samples showed up to 1,000-fold greater cytokine/chemokine levels relative to plasma. Furthermore, patients with the rs12252-C/C IFN-induced transmembrane protein-3 (IFITM3) genotype had more rapid disease progression and were less likely to survive. Compared with patients with the rs12252-T/T or rs12252-T/C genotype of IFITM3, patients with the C/C genotype had a shorter time from disease onset to the time point when they sought medical aid (hospital admission or antiviral therapy) and a shorter interval to development of the acute respiratory distress syndrome stage (reflected by shorter intervals between clinical onset and methylprednisolone treatments and higher rates of mechanical ventilator use), as well as experiencing elevated/prolonged lung virus titers and cytokine production and higher mortality. The present analysis provides reported data on the H7N9 influenza-induced "cytokine storm" at the site of infection in humans and identifies the rs12252-C genotype that compromises IFITM3 function as a primary genetic correlate of severe H7N9 pneumonia. Together with rs12252 sequencing, early monitoring of plasma cytokines is thus of prognostic value for the treatment and management of severe influenza pneumonia.

Related Stories

Genetic clue to fighting new strains of flu

December 24, 2013
(Medical Xpress)—Researchers at the University of Melbourne have discovered a genetic marker that can accurately predict which patients will experience more severe disease in a new strain of influenza (H7N9) currently found ...

A treatment for obesity-associated asthma

December 16, 2013
(Medical Xpress)—Research conducted at Boston Children's Hospital indicates that obesity might cause asthma via factors in the immune system and suggests a new way of treating asthma in obese people—who often respond ...

Predicting outcome for high-dose IL-2 therapy in cancer patients

December 2, 2013
One of the most potent forms of immunotherapy for patients with metastatic melanoma and renal cell carcinoma is high-dose (HD) bolus IL-2 therapy. Approximately 15% of patients respond to HD IL-2 therapy, with almost 5% going ...

HIV exploits a human cytokine in semen to promote its own transmission

February 7, 2013
A new report suggests that the concentration of one human cytokine, interleukin 7 (IL-7), in the semen of HIV-1-infected men may be a key determinant of the efficiency of HIV-1 transmission to an uninfected female partner. ...

Research shows that anti-fungal medicine may increase vulnerability to influenza and other viruses

November 21, 2013
Scientists at the University of Massachusetts Medical School (UMMS) and the Wellcome Trust Sanger Institute have discovered evidence that a widely used anti-fungal medicine increases susceptibility to flu infection in mice ...

IL-32 expression upregulated in chronic rhinosinusitis

April 17, 2012
(HealthDay) -- Interleukin-32 (IL-32) mRNA expression is significantly higher in biopsies obtained from patients with chronic rhinosinusitis (CRS), compared to levels found in biopsies obtained from individuals without the ...

Recommended for you

Immune cells may be key to better allergy, infection therapies

July 28, 2017
By learning how a recently discovered immune cell works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell research.

Team finds link between backup immune defense, mutation seen in Crohn's disease

July 27, 2017
Genes that regulate a cellular recycling system called autophagy are commonly mutated in Crohn's disease patients, though the link between biological housekeeping and inflammatory bowel disease remained a mystery. Now, researchers ...

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Study sheds light on how body may detect early signs of cancer

July 26, 2017
Fresh insights into how cells detect damage to their DNA - a hallmark of cancer - could help explain how the body keeps disease in check.

How genetically engineered viruses develop into effective vaccines

July 26, 2017
Lentiviral vectors are virus particles that can be used as a vaccine to stimulate the immune system to fight against specific pathogens. The vectors are derived from HIV, rendered non-pathogenic, and then engineered to carry ...

Accounting for human immune diversity increases clinical relevance of fundamental immunological research

July 26, 2017
Mouse models have advanced our understanding of immune function and disease in many ways but they have failed to account for the natural diversity in human immune responses. As a result, insights gained in the lab may be ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.